表纸
市场调查报告书

吸入抗菌药市场 - 规模、占有率、展望、机会分析 (2020-2027年):各产品类型、用途、流通管道、地区

Inhaled Antibiotics Market, by Product Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品编码 948418
出版日期 内容资讯 英文 167 Pages
商品交期: 2-3个工作天内
价格
吸入抗菌药市场 - 规模、占有率、展望、机会分析 (2020-2027年):各产品类型、用途、流通管道、地区 Inhaled Antibiotics Market, by Product Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年07月08日内容资讯: 英文 167 Pages
简介

带动吸入抗菌药市场成长的主要原因中,包含慢性呼吸疾病发生率的上升,迅速的技术进步,及新产品开发的研究开发活动增加。还有,全球市场活动的主要企业,为了扩大产品系列,强化研究开发活动,著重伙伴关系和合作等无机性成长策略的采用。标的型药物输送的吸入抗菌药应用的增加,预计促进在预测期间内的市场成长。

本报告提供全球吸入抗菌药市场相关调查,市场概要,影响市场的因素分析,各市场区隔、各地区的市场分析,并提供主要企业简介等资讯。

第1章 调查目的、前提条件

第2章 市场概要

  • 报告的说明
    • 市场定义和范围
  • 摘要整理
    • 市场明细 : 各产品类型
    • 市场明细 :各应用领域
    • 市场明细 :各流通管道
    • 市场明细 :各地区
  • Coherent Opportunity Map (COM)

第3章 市场动态、规定、趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场机会
  • 影响分析
  • 市场趋势
  • 主要的发展
  • 法规方案
  • 合并和收购方案
  • PEST分析

第4章 全球吸入抗菌药市场:冠状病毒(Covid-19)大流行的影响

  • 影响调查
  • COVID-19前的市场方案
  • COVID-19后的市场方案
  • 为抵抗COVID-19的政府措施

第5章 全球吸入抗菌药市场:各产品类型

  • 简介
  • 气雾剂
  • 干燥粉末制剂
  • 喷雾

第6章 全球吸入抗菌药市场:各用途

  • 简介
  • 肺炎
  • 气喘
  • 支气管炎
  • 其他

第7章 全球吸入抗菌药市场:各流通管道

  • 简介
  • 医院药局
  • 零售药局
  • 线上药局

第8章 全球吸入抗菌药市场:各地区

  • 简介
  • 北美
  • 南美
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第9章 竞争情形

  • 热图分析
  • 市场占有率分析
    • Gilead Sciences
    • Aradigm
    • Lupin Ltd.
    • Polyphor
    • Insmed Incorporated
    • Pharmaero
    • Savara Pharmaceuticals
    • Joincare Pharmaceutical Group
    • Pharmaxis Ltd
  • 分析师的见解

第10章 Section

目录

Title:
Inhaled Antibiotics Market, by Product Type (Aerosol, Dry Powder Formulation, and Spray), by Application (Pneumonia, Asthma, Bronchitis, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Inhaled antibiotics are used to treat chronic airway infection. The earliest experience with inhaled antibiotics involved aerosolizing antibiotics designed for parenteral administration. These formulations caused significant bronchial irritation due to added preservatives and non-physiologic chemical composition. A major therapeutic advance took place when tobramycin designed for inhalation was approved by the U.S. Food and Drug Administration (FDA) for use in patients with cystic fibrosis (CF) with chronic Pseudomonas Aeruginosa infection. Increasing application of inhaled antibiotic in targeted drug delivery is expected to drive the market growth over the forecast period.

Market Dynamics

The major factors driving growth of the inhaled antibiotics market include rising incidence of chronic respiratory disorders, rapid technological advancements, and increasing research and development activities for the development of novel products. Moreover, major players operating in the global market are focusing on adoption of inorganic growth strategies such as partnership and collaboration, in order to expand its product portfolio and strengthen their research and development activities. For instance, in October 2019, Alaxia, a French biotech company, partnered with the European consortium iABC, to accelerate the development of ALX-009, an investigational inhaled antibiotic for multi-drug resistant lung infections in people with cystic fibrosis. Under the partnership, Alaxia will provide support for setting up clinical trials and recruiting patients, and will gain access to expertise on antimicrobial agents from iABC members.

Key features of the study:

  • This report provides in-depth analysis of the global inhaled antibiotics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global inhaled antibiotics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Gilead Sciences, Aradigm, Lupin Ltd., Polyphor, Insmed Incorporated, Pharmaero, Savara Pharmaceuticals, Joincare Pharmaceutical Group, and Pharmaxis Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global inhaled antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhaled antibiotics market

Detailed Segmentation:

  • Global Inhaled Antibiotics Market, By Product Type:
    • Aerosol
    • Dry Powder Formulation
    • Spray
  • Global Inhaled Antibiotics Market, By Application:
    • Pneumonia
    • Asthma
    • Bronchitis
    • Others
  • Global Inhaled Antibiotics Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Inhaled Antibiotics Market, By Region:
    • North America
      • By Product Type:
      • Aerosol
      • Dry Powder Formulation
      • Spray
      • By Application:
      • Pneumonia
      • Asthma
      • Bronchitis
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Product Type:
      • Aerosol
      • Dry Powder Formulation
      • Spray
      • By Application:
      • Pneumonia
      • Asthma
      • Bronchitis
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product Type:
      • Aerosol
      • Dry Powder Formulation
      • Spray
      • By Application:
      • Pneumonia
      • Asthma
      • Bronchitis
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type:
      • Aerosol
      • Dry Powder Formulation
      • Spray
      • By Application:
      • Pneumonia
      • Asthma
      • Bronchitis
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product Type:
      • Aerosol
      • Dry Powder Formulation
      • Spray
      • By Application:
      • Pneumonia
      • Asthma
      • Bronchitis
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type:
      • Aerosol
      • Dry Powder Formulation
      • Spray
      • By Application:
      • Pneumonia
      • Asthma
      • Bronchitis
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Gilead Sciences *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Aradigm
    • Lupin Ltd.
    • Polyphor
    • Insmed Incorporated
    • Pharmaero
    • Savara Pharmaceuticals
    • Joincare Pharmaceutical Group
    • Pharmaxis Ltd

"*" marked represents similar segmentation in other categories in the respective section..

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Merger and Acquisition Scenario
  • PEST Analysis

4. Global Inhaled Antibiotics Market - Impact of Coronavirus (Covid-19) Pandemic

  • Impact assessment
  • Pre COVID-19 Market Scenario
  • Post COVID-19 Market Scenario
  • Government measures to combat COVID-19

5. Global Inhaled Antibiotics Market, By Product Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Aerosol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Dry Powder Formulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Spray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Inhaled Antibiotics Market, By Application, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Pneumonia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Asthma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Bronchitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Inhaled Antibiotics Market, By Distribution Channel, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

8. Global Inhaled Antibiotics Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Gilead Sciences *
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Aradigm
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lupin Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Polyphor
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Insmed Incorporated
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pharmaero
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Savara Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Joincare Pharmaceutical Group
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pharmaxis Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact